Notch Signaling Proteins: Legitimate Targets for Cancer Therapy

被引:58
|
作者
Wang, Zhiwei [1 ]
Li, Yiwei [1 ]
Sarkar, Fazlul H. [1 ]
机构
[1] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA
关键词
Notch; cancer; signal pathway; review; natural agents; cancer therapy; gamma-secretase inhibitors; oncogene; HUMAN HEPATOCELLULAR-CARCINOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITOR; HUMAN CERVICAL-CANCER; HUMAN BREAST-CANCER; CELL-CYCLE ARREST; FACTOR-KAPPA-B; ENDOTHELIAL-GROWTH-FACTOR; HUMAN LUNG CANCERS; PANCREATIC-CANCER;
D O I
10.2174/138920310791824039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteins and small peptides ( growth factors and hormones) are key molecules in maintaining cellular homeostasis. To that end, Notch signaling pathway proteins are known to play critical roles in maintaining the balance between cell proliferation, differentiation and apoptosis, and thus it has been suggested that Notch may be responsible for the development and progression of human malignancies. Therefore, the Notch signaling pathway proteins may present novel therapeutic targets, which could have promising therapeutic impact on eradicating human malignancies. This review describes the role of Notch signaling pathway proteins in cancer and how its deregulation is involved in tumor development and progression leading to metastasis and the ultimate demise of patients diagnosed with cancer. Further, we summarize the role of several Notch inhibitors especially "natural agents" that could represent novel therapeutic strategies targeting Notch signaling toward better treatment outcome of patients diagnosed with cancer.
引用
收藏
页码:398 / 408
页数:11
相关论文
共 50 条
  • [1] Notch signaling: Emerging molecular targets for cancer therapy
    Yin, Ling
    Velazquez, Omaida C.
    Liu, Zhao-Jun
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (05) : 690 - 701
  • [2] MiRNAs as Legitimate Targets for Cancer Therapy
    Wang, Zhiwei
    CURRENT DRUG TARGETS, 2013, 14 (10) : 1093 - 1093
  • [3] Top NOTCH Targets: Notch Signaling in Cancer
    Jun, H. Toni
    Stevens, Jennitte
    Kaplan-Lefko, Paula
    DRUG DEVELOPMENT RESEARCH, 2008, 69 (06) : 319 - 328
  • [4] Notch signaling as a target in multimodality cancer therapy
    Jang, MS
    Zlobin, A
    Kast, WM
    Miele, L
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2000, 2 (01) : 55 - 65
  • [5] Notch signaling, γ-secretase inhibitors, and cancer therapy
    Shih, Ie-Ming
    Wang, Tian-Li
    CANCER RESEARCH, 2007, 67 (05) : 1879 - 1882
  • [6] Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells
    Ponnurangam, Sivapriya
    Dandawate, Prasad R.
    Dhar, Animesh
    Tawfik, Ossama W.
    Parab, Rajashri R.
    Mishra, Prabhu Dutt
    Ranadive, Prafull
    Sharma, Rajiv
    Mahajan, Girish
    Umar, Shahid
    Weir, Scott J.
    Sugumar, Aravind
    Jensen, Roy A.
    Padhye, Subhash B.
    Balakrishnan, Arun
    Anant, Shrikant
    Subramaniam, Dharmalingam
    ONCOTARGET, 2016, 7 (03) : 3217 - 3232
  • [7] The epigenetics orchestra of Notch signaling: a symphony for cancer therapy
    Paniri, Alireza
    Hosseini, Mohammad Mahdi
    Amjadi-Moheb, Fatemeh
    Tabaripour, Reza
    Soleimani, Elnaz
    Langroudi, Maryam Pilehchian
    Zafari, Parisa
    Akhavan-Niaki, Haleh
    EPIGENOMICS, 2023, 15 (24) : 1337 - 1358
  • [8] Notch Signaling in Embryology and Cancer Notch Signaling in Cancer Preface
    Reichrath, Sandra
    Reichrath, Joerg
    NOTCH SIGNALING IN EMBRYOLOGY AND CANCER: NOTCH SIGNALING IN CANCER, 2020, 1287 : VII - X
  • [9] Notch -- a Goldilocks Signaling Pathway in Disease and Cancer Therapy
    Braune, Eike-Benjamin
    Lendahl, Urban
    DISCOVERY MEDICINE, 2016, 21 (115) : 189 - 196
  • [10] RhoGDI signaling provides targets for cancer therapy
    Harding, Michael A.
    Theodorescu, Dan
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (07) : 1252 - 1259